From: Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Study period of TPTD administration
−18 ~ −13 months
−12 ~ −7 months
−6 ~ 0 months
0 ~ 6 months
7 ~ 12 months
13 ~ 18 months
Patients
0
1
6
Fracture events
7